key: cord-0684507-ahnsnrpu
authors: Ladner, Jason T.
title: Genomic signatures for predicting the zoonotic potential of novel viruses
date: 2021-09-29
journal: PLoS Biol
DOI: 10.1371/journal.pbio.3001403
sha: 22c194fd75201ddb362259e6cfa7353a831c50be
doc_id: 684507
cord_uid: ahnsnrpu

Powered by metagenomics, viral discovery is outpacing our capacity for the downstream characterization needed to fully assess zoonotic potential. A study published in PLOS Biology uses machine learning to prioritize novel viruses based only on genomic signatures.

animal model studies) prohibitive. Therefore, we need sequence-based methods for prioritizing these new viruses for follow-up studies.

With this need in mind, Mollentze and colleagues developed machine learning models to predict the zoonotic potential of novel viruses based only on genomic signatures, which can be ascertained using metagenomic sequencing data. These signatures include 146 measures of viral genome composition bias ("viral features"). For example, the relative frequency of each codon, amino acid and dinucleotide. These viral features were also compared to the same metrics calculated for human RNA transcripts, thus providing measures of compositional similarity between human and viral sequences ("similarity features"). In contrast, traditional approaches have been based on overall measures of relatedness (e.g., taxonomy and genetic divergence) between novel viruses and viruses already known to infect humans.

Using sequences for 861 known virus species (from 36 families), Mollentze and colleagues show that their genome composition-based models for predicting zoonotic potential significantly outperform models based on measures of relatedness. This is true for both the viral and similarity features alone, and model performance increases further when these two feature sets are combined. In fact, their combined model predicted high or very high zoonotic potential for >70% of the viruses known to infect humans. This includes both zoonotic viruses and viruses maintained predominantly within the human population, and a very similar level of performance was observed for a set of 113 human-derived viruses that were not included in the initial training set. Mollentze and colleagues also sought to understand why their models outperformed those based on relatedness, and what they found was that not only could their measures of genome composition broadly recapitulate evolutionary relationships, they were also able to capture generalizable features that may increase the likelihood for human infection. A great example of this comes from the Anelloviridae, which is a family of ssDNA viruses that was not represented in their initial training set. Their model assigned high or very high zoonotic potential to 39/45 (86.6%) of the human-associated anellovirus species they tested. Given the complete absence of viruses from this family during model training, these predictions must be based on features shared across human-infecting viruses from different families. At this point, Mollentze and colleagues can only speculate about the mechanisms underlying these generalizable features, but this is an area ripe for future experimentation, and by studying these signatures, we may be able to shed new light on the complex interactions that occur between virus and host.

In the coming years, the pace of virus discovery is likely to further accelerate. Therefore, sequence-based prioritization approaches, like that presented by Mollentze and colleagues, will be crucial, and the performance of these approaches is likely to improve as our understanding of the virosphere grows. However, it would be unrealistic to expect genomic analysis to solve all the challenges associated with comprehensive characterization of zoonotic viruses. Even using one of the lower estimates of virus diversity in mammals (40,000 total, 10,000 zoonotic) [4] , the model described by Mollentze and colleagues would be expected to flag >3000 mammalian viruses as very high priorities and~13,000 more as high priorities for further characterization. Therefore, we also need complementary, non-genomic triage approaches, like prioritizing viruses commonly encountered at the human-animal interface [2, 5] , and we need to improve our capacity for downstream characterization of novel viruses through the development and implementation of high-throughput and highly-multiplexed assays. For example, recent developments in serology now allow antibody reactivity against 100s-1000s of viruses to be assessed using a single assay [6, 7] . In other words, models like those described in this issue by Mollentze and colleagues are welcome additions to our toolkit for pandemic prevention, but we still have a lot of work ahead of us.

Identifying and prioritizing potential human-infecting viruses from their genome sequences

How accurately can we assess zoonotic risk?

Using Metagenomics to Characterize an Expanding Virosphere

Global estimates of mammalian viral diversity accounting for host sharing

Ranking the risk of animalto-human spillover for newly discovered viruses

Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome

Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses